Skip to content

The Correlation Between Filling Pressure, Cardiac Output and Plasma Copeptin in Patients With Systolic Heart Failure

The Correlation Between Filling Pressure, Cardiac Output and Plasma Copeptin in Patients With Systolic Heart Failure

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01748006
Enrollment
30
Registered
2012-12-12
Start date
2012-06-30
Completion date
2016-06-30
Last updated
2015-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Brief summary

The relationship between the activation of the vasopressin system and central hemodynamics in heart failure (including right and left heart filling pressures and cardiac output) is not clear. The investigators intend to examine the correlation between levels of copeptin and vasopressin and the central hemodynamic system in patients with advanced (class III or IV) heart failure. The investigators also aim to examine the relationship of selected cardiac biomarkers in blood and urine with cardiac filling pressures and cardiac output in patients with decompensated heart failure. The study population will consist of 30 patients admitted to the Department of Cardiology at Copenhagen University Hospital. Only patients for whom the attending cardiologist has already decided upon right heart catheterization for clinical/treatment reasons will be recruited for the study.

Interventions

Sponsors

Finn Gustafsson
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Age \> 18 years 2. Left ventricular ejection fraction \< 40 % 3. Diagnosed symptomatic heart failure treated with heart failure medications for at least 30 days. 4. Clinical indication for right heart catheterization for clinical/treatment reasons 5. NYHA-class III-IV 6. Relevant heart failure treatment as tolerated by the patient

Exclusion criteria

1. Absence of clinical/treatment indication of right heart catheterization 2. Syndrome of Inappropriate Secretion of ADH (SIADH) 3. Recent acute myocardial infarction within the last 30 days 4. Presence of infection or inflammatory disease 5. Malignant disease 6. Pregnancy 7. Subjects unwilling or unable to provide written consent

Design outcomes

Primary

MeasureTime frame
The correlation between levels of plasma copeptin and vasopressin with left ventricular filling pressure and cardiac outputDay 1

Secondary

MeasureTime frame
The correlation between levels of plasma copeptin and vasopressin with urine aquaporin-2 concentrationDay 1
The correlation between New York Heart Association (NYHA) class and levels of plasma copeptin and vasopressinDay 1
The correlation between biomarkers levels and survival free of transplantation- and left ventricular assist device insertion1 year

Countries

Denmark

Contacts

Primary ContactFinn Gustafsson, MD, DMSc
finng@dadlnet.dk004535459743
Backup ContactLouise Balling, MD
louise.balling@dadlnet.dk004535452142

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026